Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Submitted by
admin
on December 4, 2017 - 11:43am
Source:
Endpoints
News Tags:
JNJ
hypertension
Idorsia
Actelion
Headline:
J&J adds PhIII hypertension drug to the pipeline with $230M-plus cash deal for Idorsia
Do Not Allow Advertisers to Use My Personal information
